文献速递脑血管病

Journal Club:烟雾病急性缺血性卒中患者静脉溶栓的疗效与安全性

Journal Club: Efficacy and Safety of IV Thrombolysis for Acute Ischemic Stroke Patients With Moyamoya Disease.
PubMed 文献 · Neurology · 2025-09-15

该研究基于行政数据回顾性分析烟雾病(MMD)患者静脉溶栓(IVT)的安全性与疗效,共识别3,050例MMD患者,其中214例(7.0%)接受IVT。倾向性评分匹配后IVT组212例、无IVT组818例,IVT组良好结局(回归家庭自我照顾)比例更高(53.6% vs 45.1%),颅内出血和死亡率无差异。

要点

  • MMD患者接受IVT后良好结局比例高于未接受IVT者。
  • IVT组与无IVT组的颅内出血和死亡率无差异。
  • 研究为首个大型回顾性证据提示MMD患者IVT可能安全。

核心结论

  • 本研究为首个大型回顾性研究,提供证据提示MMD患者静脉溶栓可能安全。
  • 未来需进一步研究确定IVT对MMD患者是否有获益。

研究设计与样本

  • 回顾性分析行政数据,共识别3,050例MMD患者,其中214例(7.0%)接受IVT。
  • 采用倾向性评分匹配(PSM)减少混杂,匹配后IVT组212例、无IVT组818例。

主要发现

  • IVT组良好结局(回归家庭自我照顾)比例为53.6%(95% CI 42.7%-63.3%),无IVT组为45.1%(95% CI 39.9%-50.3%)。
  • 两组颅内出血(ICH)或死亡率无差异。

临床怎么用

  • 对于MMD急性缺血性卒中患者,IVT可能安全,但需个体化评估。
  • 现有证据尚不能确定IVT的获益,临床决策应结合多因素。

局限性

  • 观察性研究,缺乏MMD或ICH定义的详细信息。
  • 缺乏24小时梗死确认影像学证据。
  • PSM技术本身存在局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The "Efficacy and Safety of IV Thrombolysis for Acute Ischemic Stroke Patients With Moyamoya Disease" study was a retrospective analysis of administrative data to examine the safety and efficacy of intravenous thrombolysis (IVT) in patients with moyamoya disease (MMD). Here, we examine this study in detail, looking at its strengths and limitations. The authors identified 3,050 patients with MMD of whom 214 (7.0%) had received IVT. The study used propensity score matching (PSM), a technique which aims to reduce confounding by matching treatment and control groups. After PSM, there were 212 patients in the IVT group and 818 patients in the no-IVT group. A higher proportion of patients in the IVT group had a good outcome (return to home with self-care) than the no-IVT group (53.6% [95% CI 42.7%-63.3%] vs 45.1% [95% CI 39.9%-50.3%]). There were no differences in intracranial hemorrhage (ICH) or mortality between groups. The main strength of this study was the large sample size acquired from nationwide data for this uncommon disease. A few limitations include (1) the observational nature of the study with lack of details about the definition of MMD or of ICH, (2) lack of confirmatory imaging evidence of infarct at 24 hours, and (3) limitations inherent to the technique of PSM. In summary, this study was the first large retrospective study to provide evidence that IVT may be safe in patients with MMD. Future studies are needed to determine whether there is benefit of IVT in these patients.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Siddiqi AZ, Singh N. Journal Club: Efficacy and Safety of IV Thrombolysis for Acute Ischemic Stroke Patients With Moyamoya Disease. Neurology. 2025. PMID: 40953346. doi:10.1212/WNL.0000000000214170

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。